Page last updated: 2024-09-04

levofloxacin and Break-Bone Fever

levofloxacin has been researched along with Break-Bone Fever in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, PL; Hung, YP; Ko, WC; Lee, NY; Li, CW; Li, MC; Liu, CC; Syue, LS; Tang, HJ; Tsai, PF1

Other Studies

1 other study(ies) available for levofloxacin and Break-Bone Fever

ArticleYear
Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Candidemia; Cefepime; Coinfection; Dengue; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcus; Taiwan

2019